uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026)
uniQure's (QURE) quarterly Depreciation & Amortization (CF) came in at $3.0 million in Q1 2026, down 34.7% year-on-year from $4.5 million in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
uniQure's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 34.7% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $13.2 million, a 9.29% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, up 16.76% from the prior year.
- Depreciation & Amortization (CF) steadied at $3.0 million in Q1 2026 per QURE's latest filing, from $3.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $4.5 million in Q1 2025 and bottomed at $2.0 million in Q2 2022.
- The 5-year median for Depreciation & Amortization (CF) is $2.7 million (2024), against an average of $3.0 million.
- Across the five-year window, Depreciation & Amortization (CF) surged 79.67% in 2023 and plunged 34.7% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $2.3 million in 2022, then jumped by 79.67% to $4.2 million in 2023, then rose by 4.01% to $4.4 million in 2024, then plunged by 31.82% to $3.0 million in 2025, then dropped by 0.47% to $3.0 million in 2026.
- Per Business Quant, the three latest QURE Depreciation & Amortization (CF) figures stand at $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Mn |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 4.19 Mn |
| Dec 31, 2023 | 4.19 Mn |